Tuesday, December 18, 2012
We've been hearing quite a bit about a new therapy called Ibrutinib (eh-BRU-teh-nib.) It's a BTK inhibitor, not chemotherapy, and it is administered in pill form instead of infusion. We hope to learn more about it in February at the Emerging Therapies Conference. But for now, here's a little preview from the ASH press conference on this drug.
Posted by Anna L. Conti at 9:38 AM
Sunday, December 2, 2012
We're hearing some very exciting news about new therapies in clinical trials and hope to get more details at the annual Emerging Therapies conference, in San Francisco, in February.
And I just want to say that having treatment at the Bryan Hemming Cancer Care Center was an extraordinary experience. It's beautiful, comfortable; and it feels safe, calm, and professional. The nurses were wonderful, but then we've always been impressed with the nurses, no matter where Dave has been treated. But this facility was better than valium for soothing anxieties and letting the nurses do their best work.
Posted by Anna L. Conti at 7:27 PM